Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)

Genomics BioSci & Tech. Revenue

Genomics BioSci & Tech. had revenue of 151.79M TWD in the quarter ending March 31, 2026, a decrease of -2.17%. This brings the company's revenue in the last twelve months to 738.40M, up 41.21% year-over-year. In the year 2025, Genomics BioSci & Tech. had annual revenue of 708.38M with 36.86% growth.

• Revenue (ttm): 738.40M
• Revenue Growth: +41.21%
• P/S Ratio: 1.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	708.38M	190.80M	36.86%
Dec 31, 2024	517.58M	121.44M	30.65%
Dec 31, 2023	396.14M	-22.86M	-5.46%
Dec 31, 2022	419.00M	29.04M	7.45%
Dec 31, 2021	389.97M	-53.21M	-12.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error